样式: 排序: IF: - GO 导出 标记为已读
-
TC-325 superiority in Malignant Gastrointestinal Bleeding - An Individual Patient Data Meta-analysis of Randomized Trials. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-09 Ali A Alali,Rapat Pittayanon,Myriam Martel,Bruno Costa Martins,Majid A Almadi,Yen-I Chen,Alan N Barkun
BACKGROUND The efficacy of topical hemostatic agents, recommended for peptic ulcer bleeding, remains poorly characterized in malignant gastrointestinal bleeding (GIB). METHODS We performed an individual patient data (IPD) meta-analysis assessing the efficacy of topical hemostatic agents in malignant GIB. The literature was searched using OVID MEDLINE, EMBASE, and ISI Web of Sciencedatabases (database
-
Primary liver cancer risk and mortality in patients with alcohol-related cirrhosis in England and Denmark: observational cohort studies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-09 Morten Daniel Jensen,Prof Joe West,Colin Crooks,Joanne R Morling,Frederik Kraglund,Tim Card,Gro Askgaard,Prof Peter Jepsen
BACKGROUND AIMS Patients with alcohol-related cirrhosis (ALD cirrhosis) have an increased risk of primary liver cancer (hepatocellular carcinoma [HCC] or intrahepatic cholangiocarcinoma [iCCA]). England recommends surveillance for HCC in these patients, while Denmark does not. METHODS We performed an observational cohort study using the English Clinical Practice Research Datalink and the nationwide
-
Management after obstetric anal sphincter injury: anorectal manometry and symptoms predict long-term fecal incontinence. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-06 Rose Qizhengyan Trieu,Yoav Mazor,Christine Verdon,Michael Jones,Anastasia Ejova,Gil Burton,Margaret Schnitzler,Allison Malcolm
OBJECTIVES Obstetric anal sphincter injury (OASI) is associated with serious morbidity and reduced quality of life. The role of anorectal manometry (ARM) to guide treatment is unclear. We aimed to define the role of ARM and symptom assessment post OASI in predicting anal incontinence at long-term follow-up. METHODS Prospective evaluation of 205 consecutive post-OASI women who underwent baseline ARM
-
Diagnosis and management of Clostridioides difficile in inflammatory bowel disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-04 Byron P Vaughn,Alexander Khoruts,Monika Fischer
Patients with IBD have an increased risk for Clostridioides difficile infection (CDI), which can lead to worse IBD outcomes. The diagnosis of CDI in IBD patients is complicated by higher C. difficile colonization rates and shared clinical symptoms of intestinal inflammation. Traditional risk factors for CDI, such as antibiotic exposure, may be lacking in IBD patients due to underlying intestinal microbiota
-
Risk factors for inadequate bowel preparation in colonoscopy: a comprehensive systematic review and meta-analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-03 Azizullah Beran,Tarek Aboursheid,Adel Hajj Ali,Hashem Albunni,Mouhand F Mohamed,Alejandra Vargas,Nwal Hadaki,Saqr Alsakarneh,Douglas K Rex,John J Guardiola
INTRODUCTION Inadequate bowel preparation (IBP) prior to colonoscopy remains a common problem. This meta-analysis aimed to assess the risk factors associated with IBP. METHODS We searched multiple databases for studies that assessed risk factors for IBP after adjustment and reported the data as adjusted odds ratios (OR) with 95% confidence intervals. Meta-analyses were conducted using a random-effects
-
Incidence trends in upper GI cancer in young adults: a nationwide time-trend analysis using 2001-2019 United States Cancer Statistics databases. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-09-03 Jeff Liang,Ryan Rastegar,Mohamad El Helou,Kushagra Mathur,Brent K Larson,Kevin Waters,Anila Vasireddy,Navikran Randhawa,Muhammad Mubarak,Rashmi Advani,Arsen Osipov,Jun Gong,Andrew Hendifar,Quin Liu,Kenneth H Park,Rabindra Watson,Stephen J Pandol,Simon Lo,Srinivas Gaddam
BACKGROUND AND AIMS Upper gastrointestinal (UGI) cancers, comprised of malignancies of the esophagus, stomach, duodenum, pancreas, liver, biliary tract, and gallbladder, are the second leading cause of cancer-related mortality in the US and is associated with significant comorbidities. Recent studies show a disproportionate rise in pancreatic and stomach cancer among young adults. This study aims to
-
Internet delivered exposure based cognitive behavior therapy for IBS - A clinical effectiveness study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-28 Hugo Wallen,Brjánn Ljótsson,Perjohan Lindfors,Erik Forsell,Hugo Hesser,Cecilia Svanborg
OBJECTIVES IBS is a common and debilitating disorder. When dietary and pharmacological interventions are not satisfactory, psychological treatment may produce good results. But the access to such treatment is scarce and therefore it is of importance to make use of technical solutions. In the present study we wanted to investigate the real-world effectiveness of an internet-delivered exposure based
-
Endoscopic Response Reduces the Risk of Subsequent Pouchitis in Patients with Crohn's Disease Like Pouch Inflammation. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-27 Maia Kayal,Hannah Posner,Darwin Jimenez,Justin Huang,Marla C Dubinsky,Jean Frederic Colombel
INTRODUCTION The aim of this study was to report the frequency and impact of endoscopic response and remission on the risk of subsequent pouchitis in patients with Crohn's disease like pouch inflammation (CDLPI) on therapy. METHODS This was a single center, retrospective study of patients >18 years with CDLPI on therapy. RESULTS Among 110 included patients with CDLPI in clinical remission, endoscopic
-
Technical factors associated with the benefit of prophylactic pancreatic stent placement during high-risk ERCP: a secondary analysis of the SVI trial dataset. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-27 B Joseph Elmunzer,Jingwen Zhang,Gregory A Coté,Steven A Edmundowicz,Sachin Wani,Raj Shah,Ji Young Bang,Shyam Varadarajulu,Vikesh K Singh,Mouen Khashab,Richard S Kwon,James M Scheiman,Field F Willingham,Steven A Keilin,Georgios I Papachristou,Amitabh Chak,Adam Slivka,Daniel Mullady,Vladimir Kushnir,James Buxbaum,Rajesh Keswani,Timothy B Gardner,Nauzer Forbes,Amit Rastogi,Andrew Ross,Joanna Law,Patrick
BACKGROUND Prophylactic pancreatic stent placement (PSP) is effective for preventing pancreatitis after endoscopic retrograde cholangiopancreatography (ERCP) in high-risk cases, but the optimal technical approach to this intervention remains uncertain. METHODS In this secondary analysis of 787 clinical trial participants who underwent successful stent placement, we studied the impact of: 1) whether
-
Proton pump inhibitors and cardiovascular adverse events: a meta-analysis of randomized controlled trials. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-27 Andrew D Mosholder,Manila Hada,Kira Leishear
INTRODUCTION Some observational studies suggest a cardiovascular risk from proton pump inhibitor (PPI) treatment, but observational data may be subject to bias. We conducted a meta-analysis of randomized controlled trial data on cardiovascular events during PPI treatment. METHODS Manufacturers of PPIs provided data from their PPI clinical trial programs. We included randomized trials with at least
-
Clinical implications of inflammation in patients with cirrhosis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-27 Victoria T Kronsten,Debbie L Shawcross
Cirrhosis-associated immune dysfunction refers to the concurrent systemic inflammation and immunoparesis evident across the disease spectrum of chronic liver disease; ranging from the low-grade inflammatory plasma milieu that accompanies compensated disease, to the intense high-grade inflammatory state with co-existent severe immune paralysis that defines acute decompensation and acute-on-chronic liver
-
Endoscopic Management of Refractory Benign Esophageal Strictures: What's New? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-27 Kulwinder Dua
-
Timing of Direct Oral Anticoagulants Resumption Following Colorectal Endoscopic Submucosal Dissection: A Nationwide Study in Japan. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-23 Chikamasa Ichita,Tadahiro Goto,Kiyohide Fushimi,Sayuri Shimizu
OBJECTIVES With the increasing use of direct oral anticoagulants (DOACs), managing these agents around endoscopic submucosal dissection (ESD) is crucial. However, due to the need for a large number of cases, studies examining the timing of resumption are lacking, resulting in varied recommendations across international guidelines. We aimed to perform a comparative study about the resumption timing
-
Quality Indicators Common to All Gastrointestinal Endoscopic Procedures. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-21 B Joseph Elmunzer,Michelle A Anderson,Girish Mishra,Douglas K Rex,Rena Yadlapati,Nicholas J Shaheen
-
Clinical and biological perspectives on non-canonical esophageal squamous cell carcinoma in rare subtypes. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-21 Sydney F Pomenti,Samuel P Flashner,Armando Del Portillo,Hiroshi Nakagawa,Joel Gabre,Anil K Rustgi,David A Katzka
Esophageal squamous cell carcinoma (ESCC) remains the most common malignancy of the esophagus worldwide. Environmental and lifestyle exposures such as alcohol and tobacco have been well defined in the pathogenesis of ESCC, acting in concert with cell intrinsic epigenomic, genomic and transcriptomic changes. However, a variety of non-environmental etiologies including Fanconi anemia, lichen planus,
-
Fecal Proteolytic Bacteria and Staphylococcal Superantigens are Associated with Abdominal Pain Severity in Irritable Bowel Syndrome. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-21 Runze Quan,Lisse Decraecker,Iris Appeltans,María Cuende-Estévez,Samuel Van Remoortel,Javier Aguilera-Lizarraga,Zheng Wang,Gareth Hicks,Jill Wykosky,Peter McLean,Alexandre Denadai-Souza,Hind Hussein,Guy E Boeckxstaens
INTRODUCTION Changes in the composition of the gut microbiota have been associated with the development of Irritable Bowel Syndrome (IBS). However, to what extent specific bacterial species relate to clinical symptoms remains poorly characterized. We investigated the clinical relevance of bacterial species linked with increased proteolytic activity, histamine production, and superantigen (SAg) production
-
Spine and sacroiliac joint involvement in newly diagnosed inflammatory bowel disease patients - clinical and magnetic resonance imaging findings from a population-based cohort. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Nora Vladimirova,Jakob Møller,Mohamed Attauabi,Gorm Madsen,Jakob Seidelin,Lene Terslev,Kasper Kjærulf Gosvig,Hartwig Roman Siebner,Sanja Bay Hansen,Viktoria Fana,Charlotte Wiell,Flemming Bendtsen,Johan Burisch,Mikkel Østergaard
BACKGROUND In IBD patients, co-occurring spondyloarthritis (SpA) leads to poorer outcomes and impaired quality of life, highlighting the importance of early detection and effective treatment. This is the first study to assess the prevalence and distribution of axial symptoms and MRI-detected involvement of the spine and sacroiliac joints (SIJs) in early IBD. METHODS Newly diagnosed IBD patients from
-
Utilizing transparent cap of endoloop in emergency hemostasis as a novel rapid clot removal procedure for acute upper gastrointestinal hemorrhage. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Zhenhao Ye,Chaoyuan Huang,Yimin Cheng,Wenjing Xu,Shijuan Luo
-
The Causal Effect of Intra-Pancreatic Fat Deposition on Acute and Chronic Pancreatitis: A Mendelian Randomization Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Hajime Yamazaki,Martin Heni,Róbert Wagner,Shunichi Fukuhara,Steven R Grossman,Sihao Han,Lang Wu,Samantha A Streicher,Brian Z Huang
INTRODUCTION Recent associative studies have linked intra-pancreatic fat deposition (IPFD) with risk of pancreatitis, but the causal relationship remains unclear. METHODS Utilizing Mendelian randomization, we evaluated the causal association between genetically predicted IPFD and pancreatitis. This approach utilized genetic variants from genome-wide association studies of IPFD (n=25,617), acute pancreatitis
-
Granulocyte colony stimulating factor improves Prednisolone responsiveness and 90-day survival in steroid eligible severe Alcohol associated Hepatitis: The GPreAH Study a randomized trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Ajay Kumar Mishra,Saggere Muralikrishna Shasthry,Rajan Vijayaraghavan,Guresh Kumar,Shiv K Sarin
BACKGROUND Severe alcohol-associated-hepatitis(SAH) carries high one-month mortality. Corticosteroids provide a modest 28 day but not 90-day survival benefit, due to development of infections and organ failures. Granulocyte colony stimulating factor(GCSF) has shown promise in SAH patients by its immunomodulatory and regenerative capabilities. We studied the safety and efficacy of combination(GCSF+Prednisolone
-
Clinical Characteristics, Endoscopic Findings, and Treatment Outcomes in Lymphocytic Esophagitis Compared to Eosinophilic Esophagitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Pierfrancesco Visaggi,Edoardo Savarino,Giulio Del Corso,Naoimh Herlihy,Matteo Ghisa,Jason M Dunn,Emanuele Marciano,Terry Wong,Michael Green,Nicola de Bortoli,Sebastian Zeki
INTRODUCTION Lymphocytic and eosinophilic esophagitis (LyE and EoE) are immune-mediated esophageal diseases. Clinical characteristics, endoscopic findings, and treatment outcomes of LyE were compared to EoE. METHODS This was an international retrospective study on adults enrolled at three centres in Europe. We recorded clinical characteristics and endoscopy findings at baseline, and symptoms, histology
-
Severe Polypharmacy Increases Risk of Hospitalization Among Older Adults with IBD. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Darren Drittel,William Schreiber-Stainthorp,Olivia Delau,Sakteesh V Gurunathan,Joshua Chodosh,Dorry L Segev,Mara McAdams-DeMarco,Seymour Katz,John Dodson,Aasma Shaukat,Adam S Faye
BACKGROUND As the inflammatory bowel disease (IBD) patient population is aging, the prevalence of polypharmacy is rising. However, data exploring the prevalence, risk factors, and clinical outcomes associated with polypharmacy among older adults with IBD are limited. AIMS To determine (i) prevalence of polypharmacy (≥5 medications) and potentially inappropriate medication (PIM) utilization in older
-
Oral breathing facilitates endoscopic operability compared to nasal breathing in peroral endoscopy: a randomized controlled trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Keitaro Takahashi,Takuya Iwama,Momotaro Muto,Kazuyuki Tanaka,Yu Kobayashi,Katsuyoshi Ando,Shin Kashima,Nobuhiro Ueno,Kentaro Moriichi,Hiroki Tanabe,Kazumichi Harada,Takashi Teramoto,Mikihiro Fujiya
INTRODUCTION Unsedated peroral endoscopy, including ultrathin endoscopy (UE) and conventional endoscopy (CE), is feasible in clinical practice but requires improved endoscopic operability and patient tolerance. Currently, the impact of breathing method on these factors remains unclear. We conducted the first randomized controlled trial comparing oral breathing (OB) and nasal breathing (NB) during both
-
Acceptance & Commitment Therapy for Adults Living With Inflammatory Bowel Disease & Distress: A Randomized Controlled Trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Colette Naude,David Skvarc,Bernadette Maunick,Subhadra Evans,Daniel Romano,Susan Chesterman,Lahiru Russell,Madeleine Dober,Matthew Fuller-Tyszkiewicz,Richard Gearry,Peter R Gibson,Simon Knowles,Andrew McCombie,Eric O,Leanne Raven,Leesa Van Niekerk,Antonina Mikocka-Walus
BACKGROUND The bidirectional relationship between disease activity and mental health in inflammatory bowel disease (IBD) has prompted investigations into the efficacy of psychotherapeutic interventions such as Acceptance & Commitment Therapy (ACT) on biopsychosocial outcomes. We aimed to examine the efficacy of an ACT Program (intervention) in comparison to a CBT-Informed Psychoeducation Program (active
-
PHYSIOLOGICAL AND PSYCHOLOGICAL FACTORS CONTRIBUTE TO REAL-TIME ESOPHAGEAL SYMPTOM REPORTING IN REFRACTORY REFLUX PATIENTS. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-20 Livia Guadagnoli,Sophie Abber,Annelies Geeraerts,Hannelore Geysen,Ans Pauwels,Jan Tack,Lukas Van Oudenhove,Tim Vanuytsel
BACKGROUND Real-time symptom reporting during ambulatory reflux monitoring plays a key role in the evaluation of esophageal symptoms, although the underlying processes are poorly understood. We aim to identify the psychological and physiological factors associated with real-time reflux symptom reporting and symptom-reflux association parameters. METHODS Adult patients with refractory reflux symptoms
-
Comparative Risk of Serious Infection With Vedolizumab vs Anti-Tumor Necrosis Factors in Inflammatory Bowel Disease. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-19 Cong Dai,Yu-Hong Huang,Min Jiang
-
Fecal Microbiota Transplantation in the Treatment of Severe Constipation in Children: Is It the Future? Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-16 Michele Di Stefano
-
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External Controls. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-14 Kris V Kowdley,Gideon M Hirschfield,Charles Coombs,Elizabeth S Malecha,Leona Bessonova,Jing Li,Nuvan Rathnayaka,George Mells,David E Jones,Palak J Trivedi,Bettina E Hansen,Rachel Smith,James Wason,Shaun Hiu,Dorcas N Kareithi,Andrew L Mason,Christopher L Bowlus,Kate Muller,Marco Carbone,Marina Berenguer,Piotr Milkiewicz,Femi Adekunle,Alejandra Villamil
OBJECTIVES Obeticholic acid (OCA) treatment for primary biliary cholangitis (PBC) was conditionally approved in the phase 3 POISE trial. The COBALT confirmatory trial assessed whether clinical outcomes in PBC patients improve with OCA therapy. METHODS Patients randomized to OCA (5-10 mg) were compared with placebo (randomized controlled trial [RCT]) or external control (EC). The primary composite endpoint
-
Active vs Passive Screening for Colorectal Cancer: Insights From the National Colonoscopy Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-14 Yasutoshi Shiratori,Naoki Ishii,Anthony Kalloo
-
US National Estimates of Contemporary Mortality Rates in Patients with Ulcerative Colitis Undergoing Colectomy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-14 Newaz Shubidito Ahmed,Satchel Krawchuk,Katherine A Buhler,Virginia Solitano,Vipul Jairath,Abdel Aziz Shaheen,Cynthia H Seow,Kerri L Novak,Richard J M Ingram,Cathy Lu,Paulo G Kotze,Gilaad G Kaplan,Remo Panaccione,Christopher Ma
OBJECTIVE Despite a growing armamentarium of medical therapies for ulcerative colitis (UC), colectomy remains an important therapeutic option. To better inform shared decision-making about surgery, we estimated the contemporary risk of mortality post-colectomy. METHODS Mortality rates were estimated using the National Inpatient Sample (2016-2020). Factors associated with post-colectomy death were evaluated
-
Validation of an Epigenetic Prognostic Assay to Accurately Risk-Stratify Patients with Barrett's Esophagus. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-14 Sarah E Laun,Lisa Kann,Jerome Braun,Stacey Gilbert,Daniel Lunz,Francia Pierre,Andrew Kalra,Ke Ma,Hua-Ling Tsai,Hao Wang,Simran Jit,Yulan Cheng,Yousra Ahmed,Kenneth K Wang,Cadman L Leggett,Ashley Cellini,Olga B Ioffe,Ali H Zaidi,Ashten N Omstead,Blair Jobe,Louis Korman,Drew Cornish,Pauline Zellenrath,Manon Spaander,Ernst Kuipers,Lorrie Perpetua,Bruce D Greenwald,Tara Maddala,Stephen J Meltzer
-
Role of Biliary Stent in Recurrence Recurrent Biliary Events Postendoscopic Retrograde Cholangiopancreatography: A Comment. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-13 Tao He,Jieyu Zou
-
Gastric Motility Assays May Not Capture the Entire Clinical Picture in Patients Using Glucagon-Like Peptide-1 Receptor Agonists. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-09 Ion A Hobai
-
Mahvash Disease: An Uncommon Condition in a Young Female Patient. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-05 Francisco Vara-Luiz,Marta Patita,Ivo Mendes,Carolina Palma,Ana Elisa Teles,Pedro Pinto-Marques
-
Further Questions Raised as to the Use of Anorectal Manometry in the Diagnostic Assessment of Dyssynergic Defecation. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-08-01 Paul F Vollebregt,Ugo Grossi,Charles H Knowles,S Mark Scott
-
Fair Is Not Square: More Evidence Linking Bowel Cleanliness to Colonoscopy Outcomes. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-31 Audrey H Calderwood
-
Endoscopic Retrograde Cholangiopancreatography in COVID-Associated Cholangiopathy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-31 Shyam Menon
-
Cap Polyposis: A Rare Cause of Rectal Bleeding. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-30 Yu-Qing Gong,Hai-Xing Wang,Wei-Feng Huang
-
Optimizing Cost-Effective Care for Chronic Constipation in General Gastroenterology Using an Office-Based, Point-Of-Care Test (RED): Cost-Effectiveness and Cost-Minimization Analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-26 Eric D Shah,William D Chey
INTRODUCTION We aimed to evaluate the cost-effectiveness/cost-savings of point-of-care anorectal function testing with an investigational device (RED) to triage therapy for chronic constipation in general gastroenterology. METHODS A Markov model was constructed to evaluate cost-effectiveness/cost-savings over a 1-year time horizon comparing empiric drug/pelvic floor physical therapy to testing guided
-
Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-26 Alexandra Gleave,Aryan Shah,Umair Tahir,Jedid-Jah Blom,Ethan Dong,Ayush Patel,John K Marshall,Neeraj Narula
INTRODUCTION To review the efficacy of various dietary interventions for induction of clinical remission in inflammatory bowel disease (IBD) and provide healthcare providers with a practical reference for recommending suitable diets for managing patients with IBD. METHODS PubMed, Medline(R), and Cochrane were searched from inception up to February 17, 2023, to identify all studies reporting information
-
Inpatient Gastroenterology Consults Have Little Utility Before Transesophageal Echocardiograms in a Prospective Cohort Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-26 Joseph Mizrahi,Jade Marhaba,Anika Paradkar,Leslie Klyachman,Eyal Menashe,Daniel S Jamorabo
INTRODUCTION Despite the well-documented safety of transesophageal echocardiograms (TEEs), inpatient gastroenterology (GI) services are called to clear patients for the procedure when they have GI symptoms or comorbidities ranging from mild to clinically significant. We aimed to assess the clinical utility of such consults in preventing TEE complications. METHODS We performed a prospective cohort study
-
Antigliadin antibodies and the brain in people without celiac disease: a case-control study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Iain D Croall,Paul A Armitage,Marios Hadjivassiliou,David S Sanders,Nigel HoggardMD
BACKGROUND Anti-gliadin antibodies (AGA) occur in approximately 10% of the general population, produced as a response to gluten. Autoimmune gluten-related disorders can have detrimental neurological effects if not properly controlled but the relevance of such "incidental" AGA is not properly established; any harm caused would indicate the gluten-free diet as a means for affected people to protect their
-
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Bishoi Aziz,Beverley Kok,Matthew Cheah,Ellina Lytvyak,Carlos Moctezuma-Velazquez,Shawn Wasilenko,Emmanuel Tsochatzis,Reena Ravikumar,Sophie Jose,Michael Allison,Bridget Gunson,Derek Manas,Andrea Monaco,Darius Mirza,Giuseppe Fusai,Nicola Owen,Douglas Thorburn,Keith Roberts,Parthi Srinivasan,Stephen Wigmore,Anuja Athale,Felicity Creamer,Bimbi Fernando,Vikram Iyer,Mansoor Madanur,Gourab Sen,Aldo J Montano-Loza
BACKGROUND AIMS Primary sclerosing cholangitis (PSC) may reoccur following liver transplantation (LT) and the diagnosis established once imaging studies demonstrate the diagnostic cholangiographic appearance. To evaluate whether the development of recurrent PSC (rPSC) is associated with cholestasis soon after LT, we studied whether changes in hepatic biochemistry within the first 12 months were linked
-
Deep Learning Model Using Stool Pictures for Predicting Endoscopic Mucosal Inflammation in Patients With Ulcerative Colitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Jung Won Lee,Dongwon Woo,Kyeong Ok Kim,Eun Soo Kim,Sung Kook Kim,Hyun Seok Lee,Ben Kang,Yoo Jin Lee,Jeongseok Kim,Byung Ik Jang,Eun Young Kim,Hyeong Ho Jo,Yun Jin Chung,Hanjun Ryu,Soo-Kyung Park,Dong-Il Park,Hosang Yu,Sungmoon Jeong,
INTRODUCTION Stool characteristics may change depending on the endoscopic activity of ulcerative colitis (UC). We developed a deep learning model using stool photographs of patients with UC (DLSUC) to predict endoscopic mucosal inflammation. METHODS This was a prospective multicenter study conducted in 6 tertiary referral hospitals. Patients scheduled to undergo endoscopy for mucosal inflammation monitoring
-
Linear-Array Endoscopic Ultrasound and Narrow-Band Imaging Measure the Invasion Depth of Nonpedunculated Rectal Lesions With Comparable Accuracy Based on a Randomized Controlled Trial. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Lingzhi Li,Jiaming He,Haiyan Hu,Yingying Wang,Weixin Li,Shaohui Huang,Jahan Rownoak,Shenglin Xu,Fang Xie,Junfen Wang,Wenting Mi,Jianqun Cai,Yaping Ye,Side Liu,Jing Wang,Yue Li
INTRODUCTION Linear-array endoscopic ultrasound (EUS) and narrow-band imaging (NBI) are both used to estimate the invasion depth of nonpedunculated rectal lesions (NPRLs). However, it is unclear which procedure is more accurate. This randomized controlled trial aimed to compare the diagnostic accuracy of linear EUS and NBI for estimating the invasion depth of NPRLs. METHODS This study is a single-center
-
The Association Between Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Exposure and Key Cirrhosis-Related Outcomes. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Roy X Wang,Marina Serper,Tamar H Taddei,David E Kaplan,Nadim Mahmud
INTRODUCTION Angiotensin-converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) may have hepatic benefits in patients with primarily chronic liver disease. ACE-I/ARB have not been evaluated in broad cohorts inclusive of those with decompensated cirrhosis. We analyzed the real-world association between ACE-I/ARB exposure and cirrhosis-related outcomes in a national cohort. METHODS
-
Esophageal Implantation Metastasis of Gastric Cancer During Specimen Retrieval After Endoscopic Submucosal Dissection. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Hideomi Tomida,Shogo Kitahata,Eiji Tsubouchi,Tomoyuki Ninomiya,Yoshio Ikeda,Yoichi Hiasa
-
Risk of Small Intestine Cancer in Inflammatory Bowel Disease: A Propensity-Matched Study from a Large Multi-Center Database in the United States. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Saqr Alsakarneh,Mohamed Ahmed,Samiya Azim,Jana G Hashash,Francis A Farraye,Hassan Ghoz
INTRODUCTION The risk of small bowel cancer (SBC) in inflammatory bowel disease (IBD) is unclear. We compared the recent trends of SBC in patients with IBD and stratified them based on disease type. METHODS We used TriNetX database to access the electronic health records for patients with IBD, ulcerative colitis (UC) and Crohn's disease (CD) from 2005-2024. We used propensity score matching to compare
-
Delivery of Outpatient Cirrhosis Care Through Tele-Visit Is Not Associated With Increased Mortality as Compared With Traditional In-Person Visits. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-25 Abhishek Shenoy,Autumn N Valicevic,Allison Lin,Grace L Su,Sameer D Saini,Hyungjin Myra Kim,Megan A Adams
INTRODUCTION Providers and patients have expressed concern that care provided through telehealth results in poorer outcomes than traditional in-person care. On the contrary, we hypothesized that patients with cirrhosis engaging in video/phone-based outpatient gastroenterology/hepatology tele-visits do not differ in mortality from those receiving in-person outpatient clinic visits. METHODS This was
-
Hidden in Plain Sight: Hymenolepsis Tapeworm Found on Polyp Biopsy During Routine Colonoscopy. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-23 Jagannath A Kadiyala,Calvin X Geng,Andrew P Copland
-
Application of Single-use Subscope Imaging System in the Diagnosis and Treatment of Cecal Diverticulitis Misdiagnosed as Acute Appendicitis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-19 Dezheng Lin,Yuping Su,Mingli Su,Zehui Guo,Jiaxing Deng,Yongcheng Chen,Xuefeng Guo
-
The Liver Cirrhosis Network Cohort Study: Cirrhosis Definition, Study Population, and Endpoints. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-17 Elliot B Tapper,David Goldberg,Neehar D Parikh,Norah A Terrault,Nicole Welch,Suzanne Sharpton,Bilal Hameed,Mandana Khalili,Andrew Stolz,Elizabeth C Verna,Robert S Brown,Arun J Sanyal,Lisa VanWagner,Daniela P Ladner,Cynthia A Moylan,Anna Mae Diehl,Patricia D Jones,Rohit Loomba,Srinivasan Dasarathy,Douglas A Simonetto,Vijay H Shah,Jasmohan S Bajaj,
INTRODUCTION One of the primary goals of the Liver Cirrhosis Network (LCN) is to develop a cohort study to better understand and predict the risk of hepatic decompensation and other clinical and patient-reported outcomes among patients with Child A cirrhosis. METHODS The LCN consists of a Scientific Data Coordinating Center and 10 clinical centers whose investigators populate multiple committees. The
-
Comparing Short-Term Dual vs Standard Quadruple Therapy for Helicobacter pylori Eradication. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-17 Yatin Lunagariya,Mit Shah,Saiprasad Lad,Shamshersingh Chauhan,Vikramaditya Rawat,Yogesh Bairwa,Chintan Tailor,Vinay Borkar,Shivani Chopra,Deepak Sasikumar,Meghraj Ingle
-
Impact of Diabetes, Drug-Induced Liver Injury, and Sepsis on Outcomes in MAFLD-Related Acute-on-Chronic Liver Failure. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-17 Ashish Kumar,Anil Arora,Ashok Choudhury,Vinod Arora,Mohamed Rela,Dinesh Kumar Jothimani,Mamun A Mahtab,Harshad Devarbhavi,Chundamanni E Eapen,Ashish Goel,Cesar Yaghi,Qin Ning,Tao Chen,Jidong Jia,Duan Zhongping,Saeed S Hamid,Amna S Butt,Wasim Jafri,Akash Shukla,Seok S Tan,Dong J Kim,Anoop Saraya,Jinhua Hu,Ajit Sood,Omesh Goyal,Vandana Midha,Girish K Pati,Ayaskant Singh,Guan H Lee,Sombat Treeprasertsuk
BACKGROUND The prevalence of Metabolic dysfunction associated fatty liver disease (MAFLD) and its complication, MAFLD-related acute on chronic liver failure (MAFLD-ACLF), is rising. Yet, factors determining patient outcomes in MAFLD-ACLF remain understudied. METHODS Patients with MAFLD-ACLF were recruited from the AARC registry. The diagnosis of MAFLD-ACLF was made when the treating unit had identified
-
Glucagon-Like Peptide Receptor Agonists Use Before Endoscopy Is Associated With Low Retained Gastric Contents: A Multicenter Cross-Sectional Analysis. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-17 Jennifer Phan,Patrick Chang,Danny Issa,Ronald Turner,Jennifer Dodge,Anders Westanmo,Rahul Karna,Lorenzo Olive,Firas Bahdi,Vahagn Aldzhyan,Mohammad Bilal,Thomas Tielleman
INTRODUCTION While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and American Society of Anesthesiologist (ASA) remains in conflict on recommendations regarding preoperative holding before endoscopy. The aim of this study was to address this by evaluating the effect of GLP1-RAs on gastric retention during upper endoscopy. METHODS
-
Older Age as a Worrisome Feature in Patients With Intraductal Papillary Mucinous Neoplasms: A Long-Term Surveillance Study. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-16 Shuichi Tange,Hiroki Oyama,Yoshikuni Kawaguchi,Ryunosuke Hakuta,Tsuyoshi Hamada,Kazunaga Ishigaki,Sachiko Kanai,Kensaku Noguchi,Tomotaka Saito,Tatsuya Sato,Tatsunori Suzuki,Mariko Tanaka,Naminatsu Takahara,Tetsuo Ushiku,Kiyoshi Hasegawa,Yousuke Nakai,Mitsuhiro Fujishiro
INTRODUCTION Aging has been implicated in the development of various cancer types. No study has specifically investigated age at intraductal papillary mucinous neoplasm (IPMN) diagnosis in relation to the long-term risk of pancreatic carcinogenesis. METHODS Within a prospective cohort of 4,104 patients diagnosed with pancreatic cysts, we identified 3,142 patients with IPMNs and examined an association
-
Mortality in Acute Severe Ulcerative Colitis - Still an Alarming and Real Complication in the Era of Advanced Therapies. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-16 Brigid Pinnuck,Kate D Lynch
-
Improving Insights Into Ultra-processed Food Consumption and Gastrointestinal Cancer Risk. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-16 Lu Hao,Jisu Xue
-
-
To Continue or Discontinue β-Blockers in Secondary Prophylaxis? That is the Dilemma. Am. J. Gastroenterol. (IF 8.0) Pub Date : 2024-07-16 Lorena Lanz-Zubiría,Norberto Carlos Chávez-Tapia